Status:
COMPLETED
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Lead Sponsor:
I.M. Sechenov First Moscow State Medical University
Conditions:
Anticoagulants
Eligibility:
All Genders
18-120 years
Phase:
NA
Brief Summary
Single-institution uncontrolled open-label trial.
Detailed Description
The single-institution uncontrolled open-label trial is to optimize the anticoagulant therapy in the out-patient practice. The study embraces patients who are advised to take the anticoagulant therap...
Eligibility Criteria
Inclusion
- the age above 18
- indications for the anticoagulant therapy
- informed consent for inclusion into trials
Exclusion
- denial to proceed in the trial
- Non-inclusion criteria:
- pregnancy and lactation
- Intracerebral hemorrhage within three preceding months
- severe mental disorders\* which could possibly affect the anticoagulant therapy dosage schedule
- anemia and a decrease in Hb by ˂100 GM/DL\*
- active gastroduodenal ulcer
- active bleeding during the preceding month
- other intensive bleeding instances as per the TIMI Score within three weeks before the inclusion
- severe hepatic impairment for over 10 points under the Child-Pugh Score
- oncology disease with the life expectancy less than one year
Key Trial Info
Start Date :
January 15 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 2 2021
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT05319340
Start Date
January 15 2014
End Date
March 2 2021
Last Update
April 8 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.